Exact Mass: 468.2809

Exact Mass Matches: 468.2809

Found 209 metabolites which its exact mass value is equals to given mass value 468.2809, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

3,17-Androstanediol glucuronide

(1S,2S,5R,7S,10R,11S,14S,15S)-14-Hydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl (2S,3S,4S,5R,6R)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid

C25H40O8 (468.2723)


3,17-Androstanediol glucuronide is a natural human metabolite of 3,17-Androstanediol generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.

   

3-alpha-Androstanediol glucuronide

(3S,5R,6S)-3,4,5-trihydroxy-6-{[(1S,2S,5R,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl]oxy}oxane-2-carboxylic acid

C25H40O8 (468.2723)


3-alpha-androstanediol glucuronide is a natural human metabolite of 3-alpha-androstanediol generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.

   

17-Hydroxyandrostane-3-glucuronide

(2R,3S,4R,5R,6R)-3,4,5-trihydroxy-6-{[(1S,2S,5R,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl]oxy}oxane-2-carboxylic acid

C25H40O8 (468.2723)


17-hydroxyandrostane-3-glucuronide is a natural human metabolite of 17-hydroxyandrostane generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. 17-Hydroxyandrostane-3-glucuronide is a natural human metabolite of 17-hydroxyandrostane generated in the liver by UDP glucuonyltransferase. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

(17alpha,23S)-17,23-Epoxy-29-hydroxy-27-norlanosta-1,8-diene-3,15,24-trione

6-(hydroxymethyl)-2,3,6,11,15-pentamethyl-5-propanoylspiro[oxolane-2,14-tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane]-1(10),3-diene-5,12-dione

C29H40O5 (468.2876)


(17alpha,23S)-17,23-Epoxy-29-hydroxy-27-norlanosta-1,8-diene-3,15,24-trione is found in herbs and spices. (17alpha,23S)-17,23-Epoxy-29-hydroxy-27-norlanosta-1,8-diene-3,15,24-trione is a constituent of Muscari comosum (tassel hyacinth)

   

3alpha-Androstanediol glucuronide

3,4,5-trihydroxy-6-[(17-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy]oxane-2-carboxylic acid

C25H40O8 (468.2723)


   

Androstanediol-17g

3,4,5-trihydroxy-6-({5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}oxy)oxane-2-carboxylic acid

C25H40O8 (468.2723)


   

Antcin B

2-Methyl-3-methylene-6-(4,10,13-trimethyl-3,7,11-trioxo-1,2,4,5,6,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl)heptanoic acid

C29H40O5 (468.2876)


   

DG(2:0/PGE2/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid

C25H40O8 (468.2723)


DG(2:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(PGE2/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid

C25H40O8 (468.2723)


DG(PGE2/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/PGE2)

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid

C25H40O8 (468.2723)


DG(2:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(PGE2/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid

C25H40O8 (468.2723)


DG(PGE2/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/PGD2/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoic acid

C25H40O8 (468.2723)


DG(2:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(PGD2/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoic acid

C25H40O8 (468.2723)


DG(PGD2/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/PGD2)

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoic acid

C25H40O8 (468.2723)


DG(2:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(PGD2/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoic acid

C25H40O8 (468.2723)


DG(PGD2/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

(2S)-1-(acetyloxy)-3-hydroxypropan-2-yl (5S,6S,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C25H40O8 (468.2723)


DG(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C25H40O8 (468.2723)


DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

(2R)-3-(acetyloxy)-2-hydroxypropyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C25H40O8 (468.2723)


DG(2:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C25H40O8 (468.2723)


DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   
   

Harbinatic acid

Harbinatic acid

C29H40O5 (468.2876)


   

Zhankuic acid A

Zhankuic acid A

C29H40O5 (468.2876)


A steroid acid that is ergosta-8,24(28)-dien-26-oic acid substituted by a methyl group at position 4 and oxo groups at positions 3, 7 and 11 (the 4alpha,5alpha stereoisomer). Isolated from Antrodia cinnamomea and Antrodia camphorata, it exhibits cytotoxic and anti-inflammatory activity.

   

6,7-Epoxy-5-hydroxy-27-methyl-1-oxowitha-2,24-dienolide

6,7-Epoxy-5-hydroxy-27-methyl-1-oxowitha-2,24-dienolide

C29H40O5 (468.2876)


   

ACMC-20n3zw

ACMC-20n3zw

C29H40O5 (468.2876)


   

10-hydroxydihydrousambarine|10-Hydroxynigritanin|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-corynan-10-ol|18, 19-Dihydrousambaridine Vi

10-hydroxydihydrousambarine|10-Hydroxynigritanin|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-corynan-10-ol|18, 19-Dihydrousambaridine Vi

C30H36N4O (468.2889)


   

Gaudichaudioside A

Gaudichaudioside A

C25H40O8 (468.2723)


   

14beta-O-(2S,3R-nilyl)rhodojaponin III

14beta-O-(2S,3R-nilyl)rhodojaponin III

C25H40O8 (468.2723)


   

datura lactone 2

datura lactone 2

C29H40O5 (468.2876)


   
   

daturametelin D

daturametelin D

C29H40O5 (468.2876)


   

2-((2E,6E,10E)-5-acetoxy-3,7,11,15-tetramethyl-12-oxohexadeca-2,6,10,14-tetraenyl)-6-methylhydroquinol|2-<(2E,6E,10E)-5-acetoxy-3,7,11,15-tetramethyl-12-oxohexadeca-2,6,10,14-tetraenyl>-6-methylhydroquinol

2-((2E,6E,10E)-5-acetoxy-3,7,11,15-tetramethyl-12-oxohexadeca-2,6,10,14-tetraenyl)-6-methylhydroquinol|2-<(2E,6E,10E)-5-acetoxy-3,7,11,15-tetramethyl-12-oxohexadeca-2,6,10,14-tetraenyl>-6-methylhydroquinol

C29H40O5 (468.2876)


   

daturametelin C|secowithametelin

daturametelin C|secowithametelin

C29H40O5 (468.2876)


   

minabeolide-5

minabeolide-5

C29H40O5 (468.2876)


   

14beta-O-(2S,3R-nilyl)rhodomollein I

14beta-O-(2S,3R-nilyl)rhodomollein I

C25H40O8 (468.2723)


   

18-hydroxy-27-norolean-12,14-dien-30-al-28-oic acid

18-hydroxy-27-norolean-12,14-dien-30-al-28-oic acid

C29H40O5 (468.2876)


   

23-nor-blepharodol

23-nor-blepharodol

C29H40O5 (468.2876)


   

11-hydroxydihydrousambarine|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-corynan-11-ol|18, 19-Dihydrousambaridine Br|18,19-Dihydro-usambaridin Br

11-hydroxydihydrousambarine|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-corynan-11-ol|18, 19-Dihydrousambaridine Br|18,19-Dihydro-usambaridin Br

C30H36N4O (468.2889)


   

(22R)-27-hydroxy-7alpha-methoxy-1-oxowitha-3,5,24-trienolide

(22R)-27-hydroxy-7alpha-methoxy-1-oxowitha-3,5,24-trienolide

C29H40O5 (468.2876)


   

(3S,5S,10S,13R,17S,23S,24S)-21,23-lactone-3,24-dihydroxystigmasta-8,14,20-trien-28-one|vernoanthelcin H

(3S,5S,10S,13R,17S,23S,24S)-21,23-lactone-3,24-dihydroxystigmasta-8,14,20-trien-28-one|vernoanthelcin H

C29H40O5 (468.2876)


   

(13S)-ent-18-(E)-coumaroyloxy-8(17)-labden-15-oic acid

(13S)-ent-18-(E)-coumaroyloxy-8(17)-labden-15-oic acid

C29H40O5 (468.2876)


   

20-OD-ingenol E

20-OD-ingenol E

C29H40O5 (468.2876)


   

ACMC-20n3zv

ACMC-20n3zv

C29H40O5 (468.2876)


   

7-hydroxypulveric acid

7-hydroxypulveric acid

C29H40O5 (468.2876)


   
   

changyediyuine III

changyediyuine III

C29H40O5 (468.2876)


   

16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-corynan-12-ol|18,19-Dihydro-usambaridin Vi

16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-corynan-12-ol|18,19-Dihydro-usambaridin Vi

C30H36N4O (468.2889)


   

changyediyuine I

changyediyuine I

C29H40O5 (468.2876)


   

Gly His Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]hexanamido]hexanoic acid

C20H36N8O5 (468.2809)


   

Gly Lys His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C20H36N8O5 (468.2809)


   

Gly Lys Lys His

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H36N8O5 (468.2809)


   

His Gly Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}hexanamido]hexanoic acid

C20H36N8O5 (468.2809)


   

His Lys Gly Lys

(2S)-6-amino-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]acetamido}hexanoic acid

C20H36N8O5 (468.2809)


   

His Lys Lys Gly

2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]hexanamido]acetic acid

C20H36N8O5 (468.2809)


   

Lys Gly His Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C20H36N8O5 (468.2809)


   

Lys Gly Lys His

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C20H36N8O5 (468.2809)


   

Lys His Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}hexanoic acid

C20H36N8O5 (468.2809)


   

Lys His Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]acetic acid

C20H36N8O5 (468.2809)


   

Lys Lys Gly His

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C20H36N8O5 (468.2809)


   

Lys Lys His Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C20H36N8O5 (468.2809)


   

18-acetoxy-PGF2α-11-acetate methyl ester

methyl 9S,15S-dihydroxy-11R,18-diacetoxy-5Z,13E-prostadienoate

C25H40O8 (468.2723)


   

(5Z,7E,22E)-(1S,3R,25R)-26,26,26-trifluoro-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,25-triol

(22E)-(25R)-26,26,26-trifluoro-1α,25-dihydroxy-22,23-didehydrovitamin D3 / (22E)-(25R)-26,26,26-trifluoro-1α,25-dihydroxy-22,23-didehydrocholecalciferol

C27H39F3O3 (468.2851)


   

(5Z,7E,22E)-(1S,3R,25S)-26,26,26-trifluoro-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,25-triol

(22E)-(25S)-26,26,26-trifluoro-1α,25-dihydroxy-22,23-didehydrovitamin D3 / (22E)-(25S)-26,26,26-trifluoro-1α,25-dihydroxy-22,23-didehydrocholecalciferol

C27H39F3O3 (468.2851)


   

3α-androstanediol glucuronide

Androstane-3alpha,17beta-diol 3-D-glucuronide

C25H40O8 (468.2723)


   

3,17-Androstanediol glucuronide

3,17-Androstanediol glucuronide

C25H40O8 (468.2723)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

3-alpha-androstanediol glucuronide

3-alpha-androstanediol glucuronide

C25H40O8 (468.2723)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

PG(P-16:0/0:0)

1-(1Z-hexadecenyl)-glycero-3-phospho-(1-sn-glycerol)

C22H45O8P (468.2852)


   

(17alpha,23S)-17,23-Epoxy-29-hydroxy-27-norlanosta-1,8-diene-3,15,24-trione

6-(hydroxymethyl)-2,3,6,11,15-pentamethyl-5-propanoylspiro[oxolane-2,14-tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane]-1(10),3-diene-5,12-dione

C29H40O5 (468.2876)


   

FA 25:5;O6

methyl 9S,15S-dihydroxy-11R,18-diacetoxy-5Z,13E-prostadienoate

C25H40O8 (468.2723)


   

LPG O-16:1

1-(1Z-hexadecenyl)-glycero-3-phospho-(1-sn-glycerol)

C22H45O8P (468.2852)


   

(22E)-(25R)-26,26,26-trifluoro-1alpha,25-dihydroxy-22,23-didehydrovitamin D3

(5Z,7E,22E)-(1S,3R,25R)-26,26,26-trifluoro-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,25-triol

C27H39O3F3 (468.2851)


   

(22E)-(25S)-26,26,26-trifluoro-1alpha,25-dihydroxy-22,23-didehydrovitamin D3

(5Z,7E,22E)-(1S,3R,25S)-26,26,26-trifluoro-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,25-triol

C27H39O3F3 (468.2851)


   

ST 19:0;O2;GlcA

17beta-Hydroxy-5alpha-androstan-3alpha-yl Beta-D-glucopyranosiduronic acid

C25H40O8 (468.2723)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

4-[(S,S)-2,3-EPOXYHEXYLOXY]PHENYL 4-(DECYLOXY)BENZOATE

4-[(S,S)-2,3-EPOXYHEXYLOXY]PHENYL 4-(DECYLOXY)BENZOATE

C29H40O5 (468.2876)


   

diethylazanide,hafnium(4+)

diethylazanide,hafnium(4+)

C16H40HfN4 (468.2718)


   

SPARC (119-122) (mouse) acetate salt

SPARC (119-122) (mouse) acetate salt

C20H36N8O5 (468.2809)


   

morfamquat (ISO) 1,1-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4-bipyridilium ion

morfamquat (ISO) 1,1-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4-bipyridilium ion

C26H36N4O4++ (468.2736)


   

Androstanediol-17g

(3alpha,5alpha,17beta)-3-Hydroxyandrostan-17-yl D-glucopyranosiduronic acid

C25H40O8 (468.2723)


   

tetrakis(diethylamino)hafnium

tetrakis(diethylamino)hafnium

C16H40HfN4 (468.2718)


   

Tagorizine

Tagorizine

C30H36N4O (468.2889)


C471 - Enzyme Inhibitor > C1322 - Lipooxygenase Inhibitor

   

5alpha-Androstane-3beta,17beta-diol 17-glucuronide

5alpha-Androstane-3beta,17beta-diol 17-glucuronide

C25H40O8 (468.2723)


   

Androstane-3alpha,17beta-diol 3-delta-glucuronide

Androstane-3alpha,17beta-diol 3-delta-glucuronide

C25H40O8 (468.2723)


   

DG(2:0/PGE2/0:0)

DG(2:0/PGE2/0:0)

C25H40O8 (468.2723)


   

DG(PGE2/2:0/0:0)

DG(PGE2/2:0/0:0)

C25H40O8 (468.2723)


   

DG(2:0/0:0/PGE2)

DG(2:0/0:0/PGE2)

C25H40O8 (468.2723)


   

DG(PGE2/0:0/2:0)

DG(PGE2/0:0/2:0)

C25H40O8 (468.2723)


   

DG(2:0/PGD2/0:0)

DG(2:0/PGD2/0:0)

C25H40O8 (468.2723)


   

DG(PGD2/2:0/0:0)

DG(PGD2/2:0/0:0)

C25H40O8 (468.2723)


   

DG(2:0/0:0/PGD2)

DG(2:0/0:0/PGD2)

C25H40O8 (468.2723)


   

DG(PGD2/0:0/2:0)

DG(PGD2/0:0/2:0)

C25H40O8 (468.2723)


   

DG(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

DG(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C25H40O8 (468.2723)


   

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0/0:0)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0/0:0)

C25H40O8 (468.2723)


   

DG(2:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

DG(2:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C25H40O8 (468.2723)


   

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/2:0)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/2:0)

C25H40O8 (468.2723)


   

Breynceanothanolic acid

Breynceanothanolic acid

C29H40O5 (468.2876)


A triterpenoid of the nor-ceanothane-type isolated from the roots of Breynia fruticosa and has been shown to exhibit cytotoxicity against human cancer cell lines.

   
   

Minabeolide 5

Minabeolide 5

C29H40O5 (468.2876)


A withanolide that is (22R,25S)-22,26-epoxycholesta-1,4-dien-26-one substituted by an oxo group at position 3 and an acetoxy group at position 18. Isolated from Paraminabea acronocephala, it exhibits anti-inflammatory activity.

   

3alpha-androstanediol glucuronide

3alpha-androstanediol glucuronide

C25H40O8 (468.2723)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H36N4O4 (468.2736)


   

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H36N4O4 (468.2736)


   

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H36N4O4 (468.2736)


   

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H36N4O4 (468.2736)


   

2-(dimethylamino)-N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

2-(dimethylamino)-N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

C26H36N4O4 (468.2736)


   

2-(dimethylamino)-N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

2-(dimethylamino)-N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

C26H36N4O4 (468.2736)


   

2-(dimethylamino)-N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

2-(dimethylamino)-N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

C26H36N4O4 (468.2736)


   

2-(dimethylamino)-N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

2-(dimethylamino)-N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

C26H36N4O4 (468.2736)


   

2-(dimethylamino)-N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

2-(dimethylamino)-N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

C26H36N4O4 (468.2736)


   

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H36N4O4 (468.2736)


   

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H36N4O4 (468.2736)


   

N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H36N4O4 (468.2736)


   

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H36N4O4 (468.2736)


   

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H36N4O4 (468.2736)


   

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H36N4O4 (468.2736)


   

1-[(1S)-2-[cyclopropyl(oxo)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-(dimethylamino)ethanone

1-[(1S)-2-[cyclopropyl(oxo)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-(dimethylamino)ethanone

C26H36N4O4 (468.2736)


   

1-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea

1-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea

C26H36N4O4 (468.2736)


   

1-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea

1-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea

C26H36N4O4 (468.2736)


   

1-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea

1-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea

C26H36N4O4 (468.2736)


   

1-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea

1-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea

C26H36N4O4 (468.2736)


   

1-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea

1-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea

C26H36N4O4 (468.2736)


   

1-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea

1-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea

C26H36N4O4 (468.2736)


   

1-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea

1-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea

C26H36N4O4 (468.2736)


   

2-(dimethylamino)-N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

2-(dimethylamino)-N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

C26H36N4O4 (468.2736)


   

2-(dimethylamino)-N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

2-(dimethylamino)-N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

C26H36N4O4 (468.2736)


   

2-(dimethylamino)-N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

2-(dimethylamino)-N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

C26H36N4O4 (468.2736)


   

N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H36N4O4 (468.2736)


   

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyridinecarboxamide

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyridinecarboxamide

C26H36N4O4 (468.2736)


   

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H36N4O4 (468.2736)


   

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H36N4O4 (468.2736)


   

N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H36N4O4 (468.2736)


   

N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H36N4O4 (468.2736)


   

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H36N4O4 (468.2736)


   

1-[(1R)-2-[cyclopropyl(oxo)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-(dimethylamino)ethanone

1-[(1R)-2-[cyclopropyl(oxo)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-(dimethylamino)ethanone

C26H36N4O4 (468.2736)


   

2-[[(2R)-3-heptanoyloxy-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2R)-3-heptanoyloxy-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C21H43NO8P+ (468.2726)


   

2-[[(2R)-2-heptanoyloxy-3-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2R)-2-heptanoyloxy-3-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C21H43NO8P+ (468.2726)


   

2,3-dihydroxypropyl [3-[(Z)-hexadec-9-enoxy]-2-hydroxypropyl] hydrogen phosphate

2,3-dihydroxypropyl [3-[(Z)-hexadec-9-enoxy]-2-hydroxypropyl] hydrogen phosphate

C22H45O8P (468.2852)


   

2-[(2-Heptanoyloxy-3-hexanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(2-Heptanoyloxy-3-hexanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C21H43NO8P+ (468.2726)


   

2-[(3-Acetyloxy-2-undecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(3-Acetyloxy-2-undecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C21H43NO8P+ (468.2726)


   

2-[(2-Decanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(2-Decanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C21H43NO8P+ (468.2726)


   

2-[Hydroxy-(2-octanoyloxy-3-pentanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-(2-octanoyloxy-3-pentanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C21H43NO8P+ (468.2726)


   

2-[(3-Butanoyloxy-2-nonanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(3-Butanoyloxy-2-nonanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C21H43NO8P+ (468.2726)


   

5alpha-androstane-3beta,17beta-diol 3-O-(beta-D-glucuronide)

5alpha-androstane-3beta,17beta-diol 3-O-(beta-D-glucuronide)

C25H40O8 (468.2723)


A steroid glucosiduronic acid that is 5alpha-androstane-3beta,17beta-diol having a single beta-D-glucuronic acid residue attached at position 3. It is a biochemical marker of peripheral tissue androgen metabolism.

   

17-hydroxyandrostane-3-glucuronide

17-hydroxyandrostane-3-glucuronide

C25H40O8 (468.2723)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

18-acetoxy-PGF2alpha-11-acetate methyl ester

18-acetoxy-PGF2alpha-11-acetate methyl ester

C25H40O8 (468.2723)


   

1-(1Z-hexadecenyl)-glycero-3-phospho-(1-sn-glycerol)

1-(1Z-hexadecenyl)-glycero-3-phospho-(1-sn-glycerol)

C22H45O8P (468.2852)


   
   

LPG P-16:0 or LPG O-16:1

LPG P-16:0 or LPG O-16:1

C22H45O8P (468.2852)


   

ST 19:1;O3;Hex

ST 19:1;O3;Hex

C25H40O8 (468.2723)


   
   
   

(2e,5s,6e,10e)-1-(2,5-dihydroxy-3-methylphenyl)-3,7,11,15-tetramethyl-12-oxohexadeca-2,6,10,14-tetraen-5-yl acetate

(2e,5s,6e,10e)-1-(2,5-dihydroxy-3-methylphenyl)-3,7,11,15-tetramethyl-12-oxohexadeca-2,6,10,14-tetraen-5-yl acetate

C29H40O5 (468.2876)


   

(1s,3r,4r,6r,7r,8r,10s,13r,14r,16r)-3,4,6,7,14-pentahydroxy-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl (2s,3s)-3-hydroxy-2-methylbutanoate

(1s,3r,4r,6r,7r,8r,10s,13r,14r,16r)-3,4,6,7,14-pentahydroxy-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl (2s,3s)-3-hydroxy-2-methylbutanoate

C25H40O8 (468.2723)


   

(2s,3r,12bs)-3-ethyl-2-{[(1s)-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]methyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-10-ol

(2s,3r,12bs)-3-ethyl-2-{[(1s)-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]methyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-10-ol

C30H36N4O (468.2889)


   

(1s,3ar,3br,5ar,9ar,9bs,11r,11ar)-3a,3b,6,6,9a-pentamethyl-1-[(2s)-2-methyl-5-oxofuran-2-yl]-7-oxo-1h,2h,3h,4h,5h,5ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-11-yl acetate

(1s,3ar,3br,5ar,9ar,9bs,11r,11ar)-3a,3b,6,6,9a-pentamethyl-1-[(2s)-2-methyl-5-oxofuran-2-yl]-7-oxo-1h,2h,3h,4h,5h,5ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-11-yl acetate

C29H40O5 (468.2876)


   

1-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-5-(hydroxymethyl)-5,8a-dimethyl-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,4,4a,6,7,8-hexahydronaphthalene-2-carbaldehyde

1-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-5-(hydroxymethyl)-5,8a-dimethyl-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,4,4a,6,7,8-hexahydronaphthalene-2-carbaldehyde

C25H40O8 (468.2723)


   

methyl (3s,5s)-7-[(1r,2r,5r,6r,8s,8ar)-5-hydroxy-2,6-dimethyl-8-[(2-methylbutanoyl)oxy]-3-oxo-2,5,6,7,8,8a-hexahydro-1h-naphthalen-1-yl]-3,5-dihydroxyheptanoate

methyl (3s,5s)-7-[(1r,2r,5r,6r,8s,8ar)-5-hydroxy-2,6-dimethyl-8-[(2-methylbutanoyl)oxy]-3-oxo-2,5,6,7,8,8a-hexahydro-1h-naphthalen-1-yl]-3,5-dihydroxyheptanoate

C25H40O8 (468.2723)


   

(2s,6r)-6-[(1r,3ar,5as,6s,9as,11ar)-6,9a,11a-trimethyl-4,7,10-trioxo-1h,2h,3h,3ah,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

(2s,6r)-6-[(1r,3ar,5as,6s,9as,11ar)-6,9a,11a-trimethyl-4,7,10-trioxo-1h,2h,3h,3ah,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C29H40O5 (468.2876)


   

(2z,6e)-9-[6-(acetyloxy)-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-6-methyl-2-(4-methylpent-3-en-1-yl)nona-2,6-dienoic acid

(2z,6e)-9-[6-(acetyloxy)-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-6-methyl-2-(4-methylpent-3-en-1-yl)nona-2,6-dienoic acid

C29H40O5 (468.2876)


   

1-(5-hydroxy-3-methylpent-3-en-1-yl)-5-(hydroxymethyl)-5,8a-dimethyl-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,4,4a,6,7,8-hexahydronaphthalene-2-carbaldehyde

1-(5-hydroxy-3-methylpent-3-en-1-yl)-5-(hydroxymethyl)-5,8a-dimethyl-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,4,4a,6,7,8-hexahydronaphthalene-2-carbaldehyde

C25H40O8 (468.2723)


   

6-(1-{9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-hydroxyethyl)-3-(methoxymethyl)-4-methyl-5,6-dihydropyran-2-one

6-(1-{9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-hydroxyethyl)-3-(methoxymethyl)-4-methyl-5,6-dihydropyran-2-one

C29H40O5 (468.2876)


   

6-[(4s,6s)-4-hydroxy-6,9a,11a-trimethyl-7,10-dioxo-1h,2h,4h,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

6-[(4s,6s)-4-hydroxy-6,9a,11a-trimethyl-7,10-dioxo-1h,2h,4h,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C29H40O5 (468.2876)


   

19-hydroxy-1,2,13,17-tetramethyl-7-(4-methylpent-3-en-1-yl)-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-7-ene-6,16,20-trione

19-hydroxy-1,2,13,17-tetramethyl-7-(4-methylpent-3-en-1-yl)-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-7-ene-6,16,20-trione

C29H40O5 (468.2876)


   

(4s,4ar,5s,8as)-1-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-5-(hydroxymethyl)-5,8a-dimethyl-4-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,4,4a,6,7,8-hexahydronaphthalene-2-carbaldehyde

(4s,4ar,5s,8as)-1-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-5-(hydroxymethyl)-5,8a-dimethyl-4-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,4,4a,6,7,8-hexahydronaphthalene-2-carbaldehyde

C25H40O8 (468.2723)


   

(3s)-5-[(1s,4ar,6r,8ar)-6-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpentanoic acid

(3s)-5-[(1s,4ar,6r,8ar)-6-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpentanoic acid

C29H40O5 (468.2876)


   

9-[6-(acetyloxy)-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-6-methyl-2-(4-methylpent-3-en-1-yl)nona-2,6-dienoic acid

9-[6-(acetyloxy)-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-6-methyl-2-(4-methylpent-3-en-1-yl)nona-2,6-dienoic acid

C29H40O5 (468.2876)


   

methyl (9r,10e,12s,13s,15z)-9,12,13-tris(acetyloxy)octadeca-10,15-dienoate

methyl (9r,10e,12s,13s,15z)-9,12,13-tris(acetyloxy)octadeca-10,15-dienoate

C25H40O8 (468.2723)


   

8-{9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-4-(methoxymethyl)-5-methyl-2,6-dioxabicyclo[3.3.1]nonan-3-one

8-{9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-4-(methoxymethyl)-5-methyl-2,6-dioxabicyclo[3.3.1]nonan-3-one

C29H40O5 (468.2876)


   

3,4,10,15-tetrahydroxy-5,5,10,15-tetramethyl-7-oxapentacyclo[12.2.1.0¹,¹¹.0⁴,⁹.0⁶,⁸]heptadecan-17-yl 3-hydroxy-2-methylbutanoate

3,4,10,15-tetrahydroxy-5,5,10,15-tetramethyl-7-oxapentacyclo[12.2.1.0¹,¹¹.0⁴,⁹.0⁶,⁸]heptadecan-17-yl 3-hydroxy-2-methylbutanoate

C25H40O8 (468.2723)


   

(6r)-6-[(1r,4s,5as,6s,9as,11ar)-4-hydroxy-6,9a,11a-trimethyl-7,10-dioxo-1h,2h,4h,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

(6r)-6-[(1r,4s,5as,6s,9as,11ar)-4-hydroxy-6,9a,11a-trimethyl-7,10-dioxo-1h,2h,4h,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C29H40O5 (468.2876)


   

(2s,3r,12bs)-3-ethyl-2-{[(1s)-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]methyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-9-ol

(2s,3r,12bs)-3-ethyl-2-{[(1s)-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]methyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-9-ol

C30H36N4O (468.2889)


   

(2e)-6-[(1s,2s,3'as,4's,5'r)-4'-(3-methoxy-3-oxopropyl)-2-methyl-5-methylidene-5'-(prop-1-en-2-yl)-2',3',3'a,4',5',6'-hexahydrospiro[cyclopentane-1,1'-inden]-2-yl]-2-methyl-4-oxohex-2-enoic acid

(2e)-6-[(1s,2s,3'as,4's,5'r)-4'-(3-methoxy-3-oxopropyl)-2-methyl-5-methylidene-5'-(prop-1-en-2-yl)-2',3',3'a,4',5',6'-hexahydrospiro[cyclopentane-1,1'-inden]-2-yl]-2-methyl-4-oxohex-2-enoic acid

C29H40O5 (468.2876)


   

methyl 9,12,13-tris(acetyloxy)octadeca-10,15-dienoate

methyl 9,12,13-tris(acetyloxy)octadeca-10,15-dienoate

C25H40O8 (468.2723)


   

8-(10,11-dihydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-8-en-2-yl)-3-methoxy-4,6-dimethyl-5-oxonon-7-enoic acid

8-(10,11-dihydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-8-en-2-yl)-3-methoxy-4,6-dimethyl-5-oxonon-7-enoic acid

C25H40O8 (468.2723)


   

(2r,6r)-6-[(1r,3ar,5ar,6s,9as,11ar)-6,9a,11a-trimethyl-4,7,10-trioxo-1h,2h,3h,3ah,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

(2r,6r)-6-[(1r,3ar,5ar,6s,9as,11ar)-6,9a,11a-trimethyl-4,7,10-trioxo-1h,2h,3h,3ah,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C29H40O5 (468.2876)


   

methyl (2r,4as,6ar,6br,12br,14as,14br)-10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-1,3,4,5,6,6b,7,13,14,14b-decahydropicene-2-carboxylate

methyl (2r,4as,6ar,6br,12br,14as,14br)-10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-1,3,4,5,6,6b,7,13,14,14b-decahydropicene-2-carboxylate

C29H40O5 (468.2876)


   

22-hydroxy-1,2,8,15,19,19-hexamethyl-13,18-dioxohexacyclo[12.8.0.0²,¹¹.0⁴,⁸.0⁵,¹⁰.0¹⁵,²⁰]docos-11-ene-5-carboxylic acid

22-hydroxy-1,2,8,15,19,19-hexamethyl-13,18-dioxohexacyclo[12.8.0.0²,¹¹.0⁴,⁸.0⁵,¹⁰.0¹⁵,²⁰]docos-11-ene-5-carboxylic acid

C29H40O5 (468.2876)


   

6-{6,9a,11a-trimethyl-4,7,10-trioxo-1h,2h,3h,3ah,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-3-methylideneheptanoic acid

6-{6,9a,11a-trimethyl-4,7,10-trioxo-1h,2h,3h,3ah,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-3-methylideneheptanoic acid

C29H40O5 (468.2876)


   

(6r)-6-[(6s)-6,9a,11a-trimethyl-4,7,10-trioxo-1h,2h,3h,3ah,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

(6r)-6-[(6s)-6,9a,11a-trimethyl-4,7,10-trioxo-1h,2h,3h,3ah,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C29H40O5 (468.2876)


   

(1s,2s,4r,5s,10r,11s,14r,15r,18s)-15-[(1s)-1-[(1s,4s,6s)-1,6-dimethyl-2-oxo-3,7-dioxabicyclo[4.1.0]heptan-4-yl]ethyl]-5,10,14-trimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-en-9-one

(1s,2s,4r,5s,10r,11s,14r,15r,18s)-15-[(1s)-1-[(1s,4s,6s)-1,6-dimethyl-2-oxo-3,7-dioxabicyclo[4.1.0]heptan-4-yl]ethyl]-5,10,14-trimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-en-9-one

C29H40O5 (468.2876)


   

6-{4-hydroxy-6,9a,11a-trimethyl-7,10-dioxo-1h,2h,4h,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-3-methylideneheptanoic acid

6-{4-hydroxy-6,9a,11a-trimethyl-7,10-dioxo-1h,2h,4h,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-3-methylideneheptanoic acid

C29H40O5 (468.2876)


   

methyl 10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-1,3,4,5,6,6b,7,13,14,14b-decahydropicene-2-carboxylate

methyl 10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-1,3,4,5,6,6b,7,13,14,14b-decahydropicene-2-carboxylate

C29H40O5 (468.2876)


   

(6r)-6-[(1r)-1-[(1r,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-hydroxyethyl]-3-(methoxymethyl)-4-methyl-5,6-dihydropyran-2-one

(6r)-6-[(1r)-1-[(1r,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-hydroxyethyl]-3-(methoxymethyl)-4-methyl-5,6-dihydropyran-2-one

C29H40O5 (468.2876)


   

3-ethyl-2-({2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}methyl)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-10-ol

3-ethyl-2-({2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}methyl)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-10-ol

C30H36N4O (468.2889)


   

(1r,4r,5r,8r)-8-[(1s,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-4-(methoxymethyl)-5-methyl-2,6-dioxabicyclo[3.3.1]nonan-3-one

(1r,4r,5r,8r)-8-[(1s,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-4-(methoxymethyl)-5-methyl-2,6-dioxabicyclo[3.3.1]nonan-3-one

C29H40O5 (468.2876)


   

(1r,5r,8r)-8-[(1r,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-4-(methoxymethyl)-5-methyl-2,6-dioxabicyclo[3.3.1]nonan-3-one

(1r,5r,8r)-8-[(1r,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-4-(methoxymethyl)-5-methyl-2,6-dioxabicyclo[3.3.1]nonan-3-one

C29H40O5 (468.2876)


   

(3ar,3br,9ar,11r)-3a,3b,6,6,9a-pentamethyl-1-[(2s)-2-methyl-5-oxofuran-2-yl]-7-oxo-1h,2h,3h,4h,5h,5ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-11-yl acetate

(3ar,3br,9ar,11r)-3a,3b,6,6,9a-pentamethyl-1-[(2s)-2-methyl-5-oxofuran-2-yl]-7-oxo-1h,2h,3h,4h,5h,5ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-11-yl acetate

C29H40O5 (468.2876)


   

1-(2,5-dihydroxy-3-methylphenyl)-3,7,11,15-tetramethyl-12-oxohexadeca-2,6,10,14-tetraen-5-yl acetate

1-(2,5-dihydroxy-3-methylphenyl)-3,7,11,15-tetramethyl-12-oxohexadeca-2,6,10,14-tetraen-5-yl acetate

C29H40O5 (468.2876)


   

(2r,6r)-6-[(1r,3ar,5as,6s,9as,11ar)-6,9a,11a-trimethyl-4,7,10-trioxo-1h,2h,3h,3ah,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

(2r,6r)-6-[(1r,3ar,5as,6s,9as,11ar)-6,9a,11a-trimethyl-4,7,10-trioxo-1h,2h,3h,3ah,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C29H40O5 (468.2876)


   

5-(6-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl)-3-methylpentanoic acid

5-(6-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl)-3-methylpentanoic acid

C29H40O5 (468.2876)


   

(2s)-2-[(1r)-1-{[(1s,5r,8as)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methoxy}-2-butoxy-2-oxoethyl]butanedioic acid

(2s)-2-[(1r)-1-{[(1s,5r,8as)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methoxy}-2-butoxy-2-oxoethyl]butanedioic acid

C25H40O8 (468.2723)


   

(4s,5s,8as)-1-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-5-(hydroxymethyl)-5,8a-dimethyl-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,4,4a,6,7,8-hexahydronaphthalene-2-carbaldehyde

(4s,5s,8as)-1-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-5-(hydroxymethyl)-5,8a-dimethyl-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,4,4a,6,7,8-hexahydronaphthalene-2-carbaldehyde

C25H40O8 (468.2723)


   

(3s)-5-[(1r,4as,5s,8as)-5-({[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-methylpentanoic acid

(3s)-5-[(1r,4as,5s,8as)-5-({[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-methylpentanoic acid

C29H40O5 (468.2876)


   

(1r,2r,4s,5s,8r,10s,14r,15s,20r,22r)-22-hydroxy-1,2,8,15,19,19-hexamethyl-13,18-dioxohexacyclo[12.8.0.0²,¹¹.0⁴,⁸.0⁵,¹⁰.0¹⁵,²⁰]docos-11-ene-5-carboxylic acid

(1r,2r,4s,5s,8r,10s,14r,15s,20r,22r)-22-hydroxy-1,2,8,15,19,19-hexamethyl-13,18-dioxohexacyclo[12.8.0.0²,¹¹.0⁴,⁸.0⁵,¹⁰.0¹⁵,²⁰]docos-11-ene-5-carboxylic acid

C29H40O5 (468.2876)


   

3-ethyl-2-({2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}methyl)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-9-ol

3-ethyl-2-({2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}methyl)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-9-ol

C30H36N4O (468.2889)


   

3,4,6,7,14-pentahydroxy-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl 3-hydroxy-2-methylbutanoate

3,4,6,7,14-pentahydroxy-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl 3-hydroxy-2-methylbutanoate

C25H40O8 (468.2723)


   

(1r,3s,4r,6s,7s,8s,10r,13s,14s,16s)-3,4,6,7,14-pentahydroxy-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl (2r,3s)-3-hydroxy-2-methylbutanoate

(1r,3s,4r,6s,7s,8s,10r,13s,14s,16s)-3,4,6,7,14-pentahydroxy-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl (2r,3s)-3-hydroxy-2-methylbutanoate

C25H40O8 (468.2723)


   

6-{1-[(9ar,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-hydroxyethyl}-3-(methoxymethyl)-4-methyl-5,6-dihydropyran-2-one

6-{1-[(9ar,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-hydroxyethyl}-3-(methoxymethyl)-4-methyl-5,6-dihydropyran-2-one

C29H40O5 (468.2876)


   

(1s,4s,5s,8r)-8-[(1r,3as,3bs,9ar,9br,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-4-(methoxymethyl)-5-methyl-2,6-dioxabicyclo[3.3.1]nonan-3-one

(1s,4s,5s,8r)-8-[(1r,3as,3bs,9ar,9br,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-4-(methoxymethyl)-5-methyl-2,6-dioxabicyclo[3.3.1]nonan-3-one

C29H40O5 (468.2876)


   

5-[5-({[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-methylpentanoic acid

5-[5-({[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-methylpentanoic acid

C29H40O5 (468.2876)


   

methyl (2r,4as,6ar,12br,14as,14br)-10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-1,3,4,5,6,6b,7,13,14,14b-decahydropicene-2-carboxylate

methyl (2r,4as,6ar,12br,14as,14br)-10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-1,3,4,5,6,6b,7,13,14,14b-decahydropicene-2-carboxylate

C29H40O5 (468.2876)


   

methyl 3,5-dihydroxy-7-{5-hydroxy-2,6-dimethyl-8-[(2-methylbutanoyl)oxy]-3-oxo-2,5,6,7,8,8a-hexahydro-1h-naphthalen-1-yl}heptanoate

methyl 3,5-dihydroxy-7-{5-hydroxy-2,6-dimethyl-8-[(2-methylbutanoyl)oxy]-3-oxo-2,5,6,7,8,8a-hexahydro-1h-naphthalen-1-yl}heptanoate

C25H40O8 (468.2723)


   

(1s,3r,4s,6r,8s,9s,10r,11r,14r,15r,17r)-3,4,10,15-tetrahydroxy-5,5,10,15-tetramethyl-7-oxapentacyclo[12.2.1.0¹,¹¹.0⁴,⁹.0⁶,⁸]heptadecan-17-yl (2s,3r)-3-hydroxy-2-methylbutanoate

(1s,3r,4s,6r,8s,9s,10r,11r,14r,15r,17r)-3,4,10,15-tetrahydroxy-5,5,10,15-tetramethyl-7-oxapentacyclo[12.2.1.0¹,¹¹.0⁴,⁹.0⁶,⁸]heptadecan-17-yl (2s,3r)-3-hydroxy-2-methylbutanoate

C25H40O8 (468.2723)


   

2-(2-butoxy-1-{[5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methoxy}-2-oxoethyl)butanedioic acid

2-(2-butoxy-1-{[5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methoxy}-2-oxoethyl)butanedioic acid

C25H40O8 (468.2723)


   

(2r,6r)-6-[(1r,4s,5as,6s,9as,11ar)-4-hydroxy-6,9a,11a-trimethyl-7,10-dioxo-1h,2h,4h,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

(2r,6r)-6-[(1r,4s,5as,6s,9as,11ar)-4-hydroxy-6,9a,11a-trimethyl-7,10-dioxo-1h,2h,4h,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C29H40O5 (468.2876)


   

(3s)-5-[(1s,4ar,6r,8as)-6-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpentanoic acid

(3s)-5-[(1s,4ar,6r,8as)-6-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpentanoic acid

C29H40O5 (468.2876)


   

(3r,4r,6r,7e)-8-[(2s,3s,7r,8e,10r,11r)-10,11-dihydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-8-en-2-yl]-3-methoxy-4,6-dimethyl-5-oxonon-7-enoic acid

(3r,4r,6r,7e)-8-[(2s,3s,7r,8e,10r,11r)-10,11-dihydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-8-en-2-yl]-3-methoxy-4,6-dimethyl-5-oxonon-7-enoic acid

C25H40O8 (468.2723)


   

3a,3b,6,6,9a-pentamethyl-1-(2-methyl-5-oxofuran-2-yl)-7-oxo-1h,2h,3h,4h,5h,5ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-11-yl acetate

3a,3b,6,6,9a-pentamethyl-1-(2-methyl-5-oxofuran-2-yl)-7-oxo-1h,2h,3h,4h,5h,5ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-11-yl acetate

C29H40O5 (468.2876)


   

15-(1-{1,6-dimethyl-2-oxo-3,7-dioxabicyclo[4.1.0]heptan-4-yl}ethyl)-5,10,14-trimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-en-9-one

15-(1-{1,6-dimethyl-2-oxo-3,7-dioxabicyclo[4.1.0]heptan-4-yl}ethyl)-5,10,14-trimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-en-9-one

C29H40O5 (468.2876)


   

(1s,2s,4s,9r,12s,13r,17s,18s,19s)-19-hydroxy-1,2,13,17-tetramethyl-7-(4-methylpent-3-en-1-yl)-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-7-ene-6,16,20-trione

(1s,2s,4s,9r,12s,13r,17s,18s,19s)-19-hydroxy-1,2,13,17-tetramethyl-7-(4-methylpent-3-en-1-yl)-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-7-ene-6,16,20-trione

C29H40O5 (468.2876)